Last updated: January 20, 2024
Sponsor: China-Japan Friendship Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stress
Vascular Diseases
Circulation Disorders
Treatment
pulmonary endarterectomy or balloon pulmonary angioplasty
Clinical Study ID
NCT05311072
Change-CTEPH
Ages > 14 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients must be diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH)
- Patients must be willing to provide informed consent
- Patients must meet the following criteria for CTEPH: a mean pulmonary artery pressures (mPAP) ≥20 mmHg combined with a pulmonary vascularresistance (PVR) ≥ 3 WU and pulmonary arterial wedge pressure (PAWP)≤ 15 mmHg documented atright heart catheterization with radiographic evidence of organized thrombi involving thepulmonary arteries after 3 months of effective anticoagulation.
Exclusion
Exclusion Criteria:
- Main cause of PH other than CTEPH
- Participation in a therapeutic clinical trial with an unknown drug;
- Withdrawal or lack of informed consent.
Study Design
Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: pulmonary endarterectomy or balloon pulmonary angioplasty
Phase:
Study Start date:
October 01, 2015
Estimated Completion Date:
December 31, 2027
Study Description
Connect with a study center
China-Japan Frendship hospital
Beijing, 100029
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.